Latest 30 News in the Life Sciences Industry
GlobeNewswire
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12 Jun 2026
GlobeNewswire
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
GlobeNewswire
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03 Jun 2026
GlobeNewswire
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
01 Jun 2026
GlobeNewswire
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
01 Jun 2026
GlobeNewswire
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
31 May 2026
GlobeNewswire
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
26 May 2026
GlobeNewswire
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
21 May 2026
GlobeNewswire
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
17 May 2026
GlobeNewswire
CJ Biomaterials Launches New Home Compostable all-PHA Extrusion Coating Resin for Paper Food Serviceware
14 May 2026
GlobeNewswire
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07 May 2026
GlobeNewswire
CJ Biomaterials and Yuhan-Kimberly Launch World’s First Reusable Nonwoven Paper Towel Made with Amorphous PHA
07 May 2026
GlobeNewswire
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
30 Apr 2026
GlobeNewswire
Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed
28 Apr 2026
GlobeNewswire
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria
27 Apr 2026
GlobeNewswire
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
24 Apr 2026
GlobeNewswire
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
24 Apr 2026
GlobeNewswire
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
14 Apr 2026
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
29 Mar 2026
GlobeNewswire
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
27 Mar 2026
GlobeNewswire
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
23 Mar 2026
GlobeNewswire
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
20 Mar 2026
GlobeNewswire
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
13 Mar 2026
GlobeNewswire
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
06 Mar 2026
GlobeNewswire
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
27 Feb 2026
Latest News All News
Upcoming Events All Events
- June 2026
- San Diego: RESI San Diego 2026
- San Diego: BIO 2026
- July 2026
- Taipei: BIO Asia-Taiwan